During the conclusion of this panel discussion, the panelists provide their final insights about managed care’s role in castration-resistant prostate cancer (CRPC).
E. David Crawford, MD, explains that as agents continue to develop for the treatment of CRPC, there is a need to better evaluate their roles. He explains that managed care needs to assess which factors are most important to patients and third-party payers.
Michael Kolodziej, MD, explains that although CRPC has entered an exciting era, there are many outstanding challenges that need to be addressed.
Jeffrey D. Dunn, PharmD, MBA, believes that managed care needs to focus on cost trends, address payment reform, invest in information technology, and improve coordination between stakeholders.
David Quinn, MD, suggests that achieving the primary goal of improving care for patients with CRPC begins with a commitment by managed care. He explains that managed care needs to determine which treatment options are the most cost-effective.
The Federal Trade Commission's (FTC's) vote to ban most employers from issuing and enforcing noncompete clauses could have varying impacts on the health care workforce; federal regulators vastly under-enforced antitrust laws in the hospital sector during the last 2 decades, resulting in increased health costs; the FDA recently found genetic evidence of the H5N1 bird flu virus in pasteurized commercially purchased milk.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Award-Winning Poster Presentations From AMCP 2024
April 23rd 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection, glucagon-like peptide-1 agonists, and more were acknowledged for their originality, relevance, clarity, bias, and quality.
Read More